Immunogen, inc. (IMGN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities:
Net loss

-29,100

4,800

-21,700

-43,449

-43,751

-41,799

-46,807

-41,624

-38,613

-13,118

-56,682

-8,867

-17,345

-34,152

-44,731

-45,922

-31,928

-33,227

-33,740

-30,474

-21,618

13,635

-22,282

-26,499

-37,451

3,812

-11,226

-21,875

-1,351

-24,393

-25,192

-22,414

-18,669

-12,753

-19,483

-16,150

-15,003

-14,233

-12,888

Adjustments to reconcile net loss to net cash (used for) provided by operating activities:
Non-cash royalty revenue related to sale of future royalties

12,997

15,313

13,202

10,412

8,488

9,281

8,441

7,242

7,190

7,587

6,503

6,439

7,613

6,710

6,184

5,944

7,380

6,291

5,684

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense on liability related to sale of future royalties and convertible senior notes

5,702

5,354

4,275

3,818

3,432

2,428

2,546

2,611

3,046

3,221

3,385

3,501

3,575

3,647

5,018

4,956

4,972

5,059

5,143

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

529

723

839

1,238

1,200

1,208

1,136

2,529

2,527

1,693

1,373

1,428

1,506

1,546

1,528

1,505

1,435

1,260

1,127

1,282

1,413

1,429

1,389

1,170

1,121

1,145

1,162

1,132

1,173

1,162

1,174

1,170

1,146

1,154

1,163

1,281

1,280

1,198

1,178

(Gain) loss on sale/disposal of fixed assets and impairment charges

709

855

-140

-1,960

-444

-145

0

0

30

-59

0

0

-180

-160

-970

-8

3

20

6

-

-

-

-

0

0

0

-20

-1

5

0

17

-74

0

18

5

-6

-1

0

-2

Gain on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

341

Amortization of deferred lease incentive obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-244

-245

-244

-

-245

-244

-245

Gain on forward contracts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2

47

-13

165

-2

-126

9

-12

-44

-8

43

8

146

Impairment charge related to restructuring

-

-

-

-

-

-

-

-

-

-

-

-

-

-

970

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock and deferred share unit compensation

3,122

3,228

3,626

2,206

5,107

4,525

4,410

4,025

3,847

2,867

2,657

3,136

2,665

3,840

4,497

4,579

7,283

4,602

5,783

2,911

3,702

3,692

5,410

3,685

3,847

3,753

4,795

2,912

2,991

2,928

3,920

2,393

2,338

2,953

2,568

1,510

1,208

1,582

1,478

Deferred rent

-

-

-

-

-

33

3

74

-15

-20

-22

-24

-25

-25

-63

-63

-42

-27

-29

-34

-34

-35

-92

-205

-129

31

6

28

27

27

27

28

27

27

27

46

-20

-14

-8

Change in operating assets and liabilities:
Accounts receivable

-7,446

7,406

94

-233

-1,468

-414

2,096

-15

-2,615

128

1,497

-2,869

1,867

1,710

-567

779

-699

-6,009

1,724

4,334

-2,355

1,271

-58

1,860

-3,782

-1,971

5,789

-5,446

4,160

433

724

-1,301

-19,784

21,213

-4,667

2,397

1,197

-833

112

Unbilled revenue/reimbursement

752

-2,008

535

-1,508

3,365

96

-1

-2,316

258

-20

793

-244

-4,727

5,318

51

382

142

-14

185

178

-42

-206

-545

-658

83

-75

-142

16

99

560

250

-88

309

-123

-390

-1,028

160

615

146

Inventory

-

-

-

-

-

-1,938

48

1,522

-670

-1,205

-1,239

257

1,033

165

1,120

-1

-629

291

-1,689

233

783

-196

-835

466

-524

1,337

968

591

-338

280

-1,118

357

-175

-41

667

-247

-905

132

258

Contract asset

-2,641

3,631

0

0

-500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid and other current assets

2,228

464

-1,688

-61

2,248

-1,858

-3,573

4,213

2,713

-1,778

-13

-1,636

1,008

-2,095

2,600

-2,454

717

2,538

-95

1,388

634

358

-525

-1,184

873

-819

559

958

-297

-491

11

-189

994

316

-1,374

-53

1,349

255

-513

Operating lease right-of-use assets

353

337

330

316

348

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-318

0

0

-700

-319

0

0

-255

Other assets

3,047

371

1,563

-1,815

-44

-232

-496

-244

884

684

-35

-45

173

-113

-292

504

-17

2,030

-62

931

-6

-59

-105

-117

-70

197

-14

-

-

-

-

-42

75

0

-17

-14

-17

27

-34

Accounts payable

-649

2,706

-552

-501

-2,698

1,247

-2,451

4,628

-757

1,764

1,401

149

-2,543

-1,127

-2,120

1,853

-2,378

1,623

1,551

1,816

709

656

138

76

931

690

-1,376

1,775

-1,983

1,490

-179

760

1,151

-1,366

-363

644

800

677

-1,972

Accrued compensation

-3,267

-4,525

-6,902

16,611

-7,373

1,480

1,792

2,853

-5,802

2,948

1,313

2,285

-2,019

200

-3,978

4,135

1,134

2,193

-5,084

1,175

2,492

967

-3,153

469

2,234

886

-2,877

1,090

1,890

737

-2,506

829

1,327

480

-2,417

855

1,407

624

-2,364

Other accrued liabilities

5,253

-88

-712

-6,277

931

-4,059

6,002

-3,551

5,447

1,594

1,979

27

775

922

38

410

1,490

-2,463

-871

2,609

-69

679

29

-310

592

-1,114

438

-607

1,591

-3,154

2,651

-396

893

-269

-95

-1,179

843

197

-236

Deferred revenue

78

-18,420

-79

-79

65,208

-1,503

534

3,679

-11,875

-25,748

75,801

24,298

-12,811

821

-74

516

-1,232

-8,066

464

-709

19,813

-36,276

-2,983

174

-980

-8,526

-7,343

-131

-6,659

523

-965

-1,001

-568

18,975

813

-859

-936

44,067

-43

Operating lease liability

-702

-682

-644

-623

-556

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from landlord for tenant improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-41

-

-

-

-

-2,700

83

874

393

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used for) provided by operating activities

-28,315

-32,557

-35,000

-31,013

10,203

-41,285

-39,856

-35,326

-49,955

-29,409

45,934

24,079

-32,959

-35,812

-47,844

-32,907

-26,079

-34,139

-31,351

-28,453

7,545

-15,484

-18,899

-18,921

-13,100

1,946

-23,575

-11,612

-5,978

-21,703

-21,006

-16,173

5,919

-12,469

-11,565

-13,932

-12,452

33,678

-15,283

Proceeds from maturities or sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,201

Purchases of property and equipment

21

83

407

228

2,127

1,026

2,093

1,099

1,028

269

68

342

437

224

1,182

1,770

3,479

1,750

3,377

2,919

1,916

882

1,708

3,473

2,414

1,725

572

1,355

377

1,072

966

1,126

948

280

554

497

655

529

348

Proceeds from sale of equipment

1,426

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used for) investing activities

1,405

2,229

-407

-228

-2,127

-1,026

-2,093

-1,099

-1,028

-269

-68

-342

-437

-224

-1,182

-1,770

-3,479

-1,750

-3,377

-2,397

-2,438

-882

-1,708

-3,473

-2,414

-1,726

-572

-1,339

-307

-1,038

-1,012

-1,130

-948

-298

-592

-461

-662

-486

949

Cash flows from financing activities:
Payments from settlement of forward contracts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16

-70

-34

46

4

0

18

38

-36

7

-43

-96

Proceeds from issuance of common stock under stock plans

240

2,062

73

670

68

1,358

124

560

2,259

-

-

-

-

-

0

182

188

329

4,462

2,997

116

1,172

144

579

1,502

3,030

4,025

1,808

1,367

163

688

2,981

1,917

1,374

716

1,806

441

352

120

Proceeds from common stock issuance, net of $229 of transaction costs

97,744

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-15

94,006

-

-

-

-

-

-

-

-

Net cash provided by financing activities

97,984

2,062

73

670

68

1,358

96

163,100

2,259

-

-

-

-

-

0

96,790

188

329

4,462

197,132

116

1,172

144

579

1,502

3,030

4,025

1,808

1,367

148

94,694

2,981

1,917

1,374

716

89,786

441

352

120

Net change in cash and cash equivalents

71,074

-28,266

-35,334

-30,571

8,144

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-48,724

-

44,514

23,769

-33,396

-36,036

-49,026

62,113

-29,370

-35,560

-30,266

166,282

5,223

-15,194

-20,463

-21,815

-14,012

3,250

-20,122

-11,143

-4,918

-22,593

72,676

-14,322

6,888

-11,393

-11,441

75,393

-12,673

33,544

-14,214